CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-17 | King Gary A. Exec. VP International Ops | Shares withheld for taxes | −5,400 | $41.39 | $224K | 80,573 |
| 2015-09-15 | McDade Ralph L President Myriad RBM, Inc. | Grant or award | +24,000 | 57,345 | ||
| 2015-09-15 | Wenstrup Richard Chief Medical Officer | Grant or award | +11,500 | 23,000 | ||
| 2015-09-15 | Ford Alexander President, MGL | Grant or award | +16,500 | 36,031 | ||
| 2015-09-15 | King Gary A. Exec. VP International Ops | Grant or award | +34,500 | 85,973 | ||
| 2015-09-02 | MARSH RICHARD M E.V.P., General Counsel | Gift | −1,000 | 73,227 | ||
| 2014-03-07 | HENDERSON JOHN T Director | Exercise or conversion | +20,000 | $7.60 | $152K | 24,000 |
| 2014-03-07 | HENDERSON JOHN T Director | Sale | −20,000 | $37.86 | $757K | 4,000 |
| 2014-03-07 | HENDERSON JOHN T Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −20,000 | 5,000 | ||
| 2014-03-05 | HENDERSON JOHN T Director | Exercise or conversion | +5,000 | $7.60 | $38K | 9,000 |
| 2014-03-05 | HENDERSON JOHN T Director | Sale | −5,000 | $37.59 | $188K | 4,000 |
| 2014-03-05 | HENDERSON JOHN T Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −5,000 | 25,000 | ||
| 2012-03-07 | King Gary A. Exec. VP International Ops | Grant or award · Incentive Stock Option (right to buy) | +4,170 | 4,170 | ||
| 2012-03-07 | King Gary A. Exec. VP International Ops | Grant or award · Non-Qualified Stock Option (right to buy) | +21,830 | 21,830 | ||
| 2012-03-07 | Capone Mark Christopher President, MGL | Grant or award · Incentive Stock Option (right to buy) | +4,170 | 4,170 | ||
| 2012-03-07 | Capone Mark Christopher President, MGL | Grant or award · Non-Qualified Stock Option (right to buy) | +47,830 | 47,830 | ||
| 2010-05-10 | Capone Mark Christopher President, MGL | Exercise or conversion | +2,814 | $9.04 | $25K | 45,268 |
| 2010-05-10 | Capone Mark Christopher President, MGL | Exercise or conversion · Incentive Stock Option (right to buy) | −2,814 | 4,958 | ||
| 2010-05-07 | Evans James S Chief Financial Officer | Exercise or conversion | +8,750 | $4.44 | $39K | 43,041 |
| 2010-05-07 | Evans James S Chief Financial Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −8,750 | 0 |
Page 53 of 60 · 1,194 trades